Sorry, you need to enable JavaScript to visit this website.

NYVEPRIA (pegfilgrastim-apgf) Overdosage

10 OVERDOSAGE

Overdosage of pegfilgrastim products may result in leukocytosis and bone pain. Events of edema, dyspnea, and pleural effusion have been reported in a single patient who administered pegfilgrastim on 8 consecutive days in error. In the event of overdose, the patient should be monitored for adverse reactions [see Adverse Reactions (6)].

What's New

No Current Announcements.

Search

Please enter your search term(s) for NYVEPRIA